2023-08-30 08:09:11 ET
More on Emergent
- Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
- Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
- Emergent BioSolutions Inc. 2023 Q2 - Results - Earnings Call Presentation
- Emergent BioSolutions, Inc. ( EBS ) Q2 2023 Earnings Call Transcript
- Benchmark cuts Emergent BioSolutions to hold as company restructures
- Emergent BioSolutions to cut 400 jobs, streamline operations
- Emergent BioSolutions up 8% on up to $704M Ebola contract
- Seeking Alpha’s Quant Rating on Emergent Biosolutions
For further details see:
Emergent to launch over-the-counter opioid overdose therapy in September